Digi Bio
Single cell, AI-driven, lab-on-a-chip technology to accelerate the development of new therapies.
About Digi Bio
We measure each cell individual fate and performance to determine which drug performs best.
Recent Funding lists Digi Bio under AI infrastructure and compute (also Health and bio). It went through HAX (HAX 10). It was founded by Federico Muffatto.
Funding rounds
Founders and team
FM
Investors
Similar AI infrastructure and compute companies
MModelyo$17M · Oct 2026
SSento$17.95M Series A · Oct 2026
LLiufang Technology$14.96M Series B+ · Oct 2026
EEMode Photonix$1M Pre Seed · Oct 2026
TTrimagnetix$1M Seed · Oct 2026
MMueon$65M Series A · Oct 2026
Questions and sources
Digi Bio: questions and answers
- Who invested in Digi Bio?
- Investors on record for Digi Bio: HAX.
- Who founded Digi Bio?
- Digi Bio was founded by Federico Muffatto (Founder & CEO).
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/digi-bio (get a free API key).